Brain Cancer

Cerebral Glioblastoma

Male, 35 years

Patient Internal 777141807

ICD-10 code

C71.8 Malignant Neoplasm of Overlapping Sites of Brain

Diagnosis (Incl. Metastases/Stage) and Year

January 2021
Glioblastoma, WHO Grade IV, ATRX (-), MGMT (-), IDH (+).

Previous Treatment

Surgery, Radiation Therapy, Chemotherapy (Temozolomide).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of Glioblastomas being around 14 months from diagnosis.

Treatment Provided

Autologous DCV (11 doses) and CIK (16 doses) over a period of 17 months.

Patient Survival/Condition and Year
Date of Review: 17/02/2024

The patient has survived for 31 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy and Radiation Therapy, has extended patient survival by an estimate of around 18 months.